Cancer Imaging Program (CIP)
The NCI Cancer Imaging Program (CIP) fosters advances in in vivo medical imaging sciences through support of basic and applied research in cancer imaging. It also promotes imaging in clinical trials in order to gain greater understanding of the pathways of cancer biology for the benefit of cancer patients and people at cancer risk.
CIP Resources
-
NCI Alliance for Nanotechnology in CancerUsing nanotechnology to improve cancer diagnosis, treatment, and prevention
-
Cancer Imaging ArchiveThe Cancer Imaging Archive (TCIA) is a service which de-identifies and hosts a large publicly available archive of medical images of cancer.
-
Quantitative Imaging NetworkPromotes research, development and clinical validation of quantitative imaging tools and methods.
-
Co-Clinical Imaging ResearchFocusing on optimization of quantitative imaging methods for precision medicine in preclinical and clinical settings.
Cancer Imaging Program (CIP) Organization
CIP Related Funding Opportunities
-
Molecular Imaging of Inflammation in Cancer
PAR-24-311: Expires: 07Jan2028
-
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems
PAR-25-079: Expires: 07Jan2027
-
NCIs Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis
PAR-25-081: Expires: 07Jan2027
-
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy
PAR-25-175: Expires: 07Jan2028
-
Innovative Research in Cancer Nanotechnology
PAR-25-106: Expires: 04May2026
-
Toward Translation of Nanotechnology Cancer Interventions
PAR-25-336: Expires: 15Nov2027